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Cancer cells require both energy and material to survive and duplicate in a competitive 
environment. Nutrients, such as amino acids (AAs), are not only a caloric source, as they can 
modulate cell metabolism and modify hormones homeostasis. Our hypothesis is that the 
environmental messages provided by AAs rule the dynamics of cancer cells life or death, and 
the alteration of the balance between essential (EAAs) and non-essential amino acids 
(NEAAs) (lower and higher than 50%, respectively) present in nutrients may represent a key 
instrument to alter environment-dependent messages thus mastering cancer cells destiny. In 
this study, two amino acid mixtures, one exclusively consisting of EAAs and the other 
consisting of 85% essential and 15% non-essential amino acids, were tested to explore their 
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mechanisms involved. Both mixtures exerted a cell-dependent anti-proliferative, cytotoxic 
effect involving the inhibition of proteasome activity and the consequent activation of 
autophagy and apoptosis. These results, besides further validating the notion of the peculiar 
interdependence and extensive crosstalk between the ubiquitin-proteasome system and 
autophagy, indicate that variation in the ratio of EAAs and NEAAs can deeply influence 
cancer cell survival. Consequently, customization of dietary ratios among EAAs and NEAAs 
by specific amino acid mixtures may therefore represent a promising anticancer strategy able 
to selectively induce death of cancer cells through the induction of apoptosis via both 
ubiquitin-proteasome system inhibition and autophagy activation. 
 
1. INTRODUCTION 
The dissection of host-tumor relationship stimulated researchers to study the link between 
nutrition and altered protein/nitrogen metabolism in cancer [1, 2]. Malnutrition correlates 
with poor quality of life, increased mortality, morbidity, and chemotherapy-induced toxicity 
in cancer patients. Recent findings showed that calorie restriction counteracts the 
development of cancer, whereas positive results were obtained supplementing cancer cells 
with specific nutrients [3]. Selected nutrients, such as amino acids (AAs), besides being a 
caloric supply, are essential for protein synthesis, since they specifically influence gene 
transcription and translation, thus modulating the effects of hormones, energy availability and 
cell integrity [4]. AAs role in the maintenance of life is established, since they are the only 
source of nitrogen for synthetic and metabolic purposes. In fact, although glucose and lipids 
can be synthesized from AAs, the production of AAs from glucose and lipids is not possible 
due to the absence of nitrogen. Essential amino acids (EAAs) availability is the major 
limiting factor in maintaining synthesis of new proteins, since they allow endogenous 
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and available as fuels and substrates in foods and mammal proteins. Few studies reported 
either on the toxicity of AAs in human health or on the safe limits for their supply and the 
effect of nutrients on normal and cancer tissues is not well defined [5, 6]. Among EAAs, only 
methionine is particularly toxic at high concentrations, and anemia [7] and a marked 
depression in rats growth were observed when this AA was introduced in their diet [8]. 
Methionine toxicity is mainly due to a primary metabolic role of the input of methionine, 
which should necessarily match cysteine/cystine requirements. Along this metabolic 
pathway, methionine is transformed in the intermediate homocysteine (Hcys) that is involved 
in the enhanced expression of HMG-CoA reductase in artery walls and correlates with 
impaired NO production and increased oxidative damage [5]. When sulfur-containing AAs 
needs are not matched by a well-balanced intake of cysteine/cystine [9], metabolic needs will 
choke S-adenosyl methionine and folate dependent methylations pathways [10, 11]. 
Differently, arginine and glutamine are “conditionally-essential” AAs since normal 
metabolism cannot maintain sufficient levels for cellular requirements in specific pathologies 
if EAAs would not be available in sufficient amounts [5]. Positive effects were reported upon 
diet supplementation with EAAs in age-associated alterations with enhanced protein 
synthesis, physical strength and arterial pO2 observed in COPD-affected patients [12]. A 
branched-chain AAs-enriched mixture enhanced mitochondrial biogenesis and SIRT-1 
expression in cardiac and skeletal muscles, increasing average life span of male mice. 
Additionally, upregulation of ROS defense system genes was detected, resulting in a decrease 
of oxidative damage [13]. EAAs oral administration to institutionalized elderly patients 
resulted in improved depressive symptoms, with enhanced levels of serotonin and physical 
performance and amelioration of health-related quality of life [14], in agreement with 
previous report on diabetic chronic heart failure patients [15]. Roomi et al. tested the effects 



















This article is protected by copyright. All rights reserved. 
micronutrients on HeLa xenograft-bearing female nude mice demonstrating the inhibition of 
tumor growth and enhancement of extracellular matrix proteins, suggesting its therapeutic 
value in the treatment of cervical cancer [16]. Tumor growth inhibition and decrease of the 
values of several cancer markers, including Ki67, matrix metalloproteinase-2 and -9, vascular 
endothelial growth factor, terminal deoxynucleotidyl transferase dUTP nick end labeling and 
B-cell lymphoma 2, cyclooxygenase 2, inducible nitric oxide synthase and glutathione S-
transferase π were observed [17]. Furthermore, the same mixture showed therapeutic 
potential in the treatment of breast cancer [18]. Diet supplementation with EAAs reduced the 
toxic side effects of doxorubicin in in vivo experiments and promoted cancer cells mortality 
in vitro [19]. Since current cancer treatments based on chemotherapy and radiotherapy are 
toxic and associated with severe side effects, there is a need for safe, effective and natural 
remedies that can control cancer progression and expansion. Based on this premise, this study 
investigates the effects of two AAs mixtures, one entirely composed of EAAs and the other 
consisting of 85% essential and 15% non-essential AAs, on normal and cancer cells and 
dissects the molecular mechanisms involved. Both mixtures induced a cell-type dependent 
toxicity with proteasome inhibition and autophagy activation, ultimately driving to apoptosis. 
We conclude that tuning the ratio between EAA and NEAA, still being tolerable for normal 
mammals, may represent a promising approach in understanding cancer physiology, 
eventually providing additional options for the (co-)treatment of cancer through the 
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2. RESULTS 
2.1 Effects of AAs supplementation on cellular apoptosis 
Cellular viability was evaluated upon treatment with both AAs formulations (1% w/v final 
concentration, as reported in tab. 1) in several cell lines: in detail, MCF10A (not transformed 
cells) and HeLa, HCT116, MCF7, HepG2, CaCo2 (cancer cell lines). Results are shown in 
figure 1. The concentration used allowed us to assess the occurrence of cell death and, 
simultaneously, the exploration of intracellular pathways. Tumor cells, in particular HCT116, 
showed an increased mortality compared to normal MCF10A cells, which were similarly 
affected by both solutions (Figure 1). Moreover, viability was assessed using the caspase 
inhibitor zVAD-fmk to block apoptosis to explore the link between apoptosis and the 
decreased viability. The addition of zVAD-fmk resulted in an increased cell viability, 
indicating that the two mixtures induced a caspases-mediated apoptosis. To confirm the 
activation of the cell death cascade additional apoptotic markers were investigated in HeLa 
and HCT116 cancer cells that showed the highest sensitivity to the treatment with AAs 
formulation. Caspase-3 is associated with the initiation of the death cascade [20]. A cell-type 
dependent activation of the enzyme was observed (Figure 2, panel C). Caspase-3 activity 
resulted significantly enhanced in tumor cell lines upon exposure to both solutions, whereas a 
significant increase in its activity was observed upon exposure of the control line to the 85% 
EAAs and 15% NEAAs solution. A remarkable increase in caspase-3 activity was observed 
in HCT116 cells treated with the mix, whereas in HeLa cells caspase-3 was similarly 
activated upon supplementation with both formulations. PARP is a nuclear protein involved 
in several cellular processes, including DNA repair, DNA replication, cell proliferation and 
differentiation. During apoptosis, PARP is cleaved by caspases and prevents DNA repair 
activating a calcium/magnesium-dependent endonuclease that results in internucleosomal 
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three cell lines treated with the AAs mix, whereas, upon 100% EAAs exposure, a remarkable 
decrease was only observed in HCT116 cells (Figure 2, panel B). Apoptotic activation was 
finally confirmed by the decreased levels of the anti-apoptotic protein Mcl-1 (figure 2 panel 
A-B) and the analysis of DNA fragmentation and nuclear condensation [22]. Figure 2, Panel 
C, clearly shows DNA fragmentation in cancer cells and in particular in HeLa cells treated 
with the amino acids mix. The Hoechst 33342 staining confirmed that the treatment with both 
formulations induced morphological changes in the nuclei, peculiarly evident in HCT116 
cells, and including the nuclei shrinkage and chromatin condensation (Figure 2, panel D). 
Effects on MCF10A, HCT116 and HeLa cells proliferation were further investigated through 
the detection of PCNA, an auxiliary factor for DNA polymerase σ, described as a DNA 
sliding clamp that acts as a polymerase processivity factor. Besides DNA replication, PCNA 
function is associated with chromatin remodeling, sister-chromatid cohesion, cell cycle 
control and DNA repair [23]. Upon treatment, a significant decrease in PCNA expression was 
observed in cancer cells and, in particular, in Hela cells. High levels of PCNA were detected 
in untreated cancer cells consistently with published data demonstrating a correlation 
between elevated PCNA levels and cell transformation, with cancer cells showing 5-6-fold 
higher levels of PCNA than immortalized non-cancer cells [24]. MCF10A cells showed no 
significant differences in PCNA levels after treatments (Figure 2, panel A).  
 
2.2 Effects of AAs supplementation on proteasome functionality  
The ChT-L, T-L, PGPH and BrAAP proteasomal activities were measured in cell lysates 
using fluorogenic substrates (figure 3). Amino acids supplementation did not affect 
proteasome activities in normal MCF10A cells. Conversely, a significant, cell-type and 
formulation-dependent inhibition was observed in cancer cells. In HeLa cells, the tested 



















This article is protected by copyright. All rights reserved. 
formulations. In HCT116 cells, the T-L and ChT-L activities were more susceptible to the 
100% EAAs solution. UPS functionality was further explored by measuring the ChT-L 
activity of the 26S proteasome, the complex that needs ATP and ubiquitinated substrates for 
final degradation (figure 3, panel A). Cancer cells exhibited a remarkable decline of the 
enzymatic activity that in HCT116 cells was more evident upon 100% EAAs treatment. 
Interestingly, HCT116 and HeLa cells have higher basal levels of proteasomal activity 
compared to non-transformed MCF10A cells. This difference, mostly evident between 
MCF10A and HCT116 cells, concerns all the tested components and is in line with other 
reports demonstrating higher proteasomal activity in tumor cell lines [25, 26]. Treatments 
with both mixtures bring these higher levels down to the values evidenced in normal cells. 
To gain insight into UPS modulation, the levels of a series of established ubiquitinated 
proteasomal substrates were determined. Total ubiquitinated proteins and p53 notably 
increased in HCT116 and HeLa cells treated with the EAAs/NEAAs mix. A lower, but still 
significant increase was observed upon supplementation of HCT116 with the 100% EAAs 
solution (Figure 4, Panel B). In accordance with the data on the proteasome activity, no 
changes were observed in the levels of ubiquitinated proteins in MCF10A cells. Proteasome 
inhibition resulted in the downregulation of the S-phase kinase-associated protein 2 (Skp-2), 
accumulation of p27, and cell cycle arrest [27]. In accordance with proteasome inhibition and 
with the reduced expression of PCNA, levels of p27 markedly increased in cancer cells 
treated with both the 100% EAAs solution and the mix (figure 4, panel B), further confirming 
that AAs supplementation negatively affect cell cycle progression. 
 
2.3 Effects of AAs supplementation on autophagy 
Next, we monitored the effects of both mixtures on the functionality of the autophagic 
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autophagy-related proteins LC3-II, beclin-1 and p62. Globally, AAs supplementation favored 
a significant increase of cathepsins B and L activities in all the cell lines. In detail, the 
EAAs/NEAAs mix strongly activated both cathepsins in HeLa cells. In HCT116 cells, both 
enzymes were differently activated in response to the treatments: cathepsin L was 
considerably activated in the presence of 100% EAAs formulation, whereas the activity of 
cathepsin B was mainly increased by EAAs/NEAAs mix. A significant activation of both 
enzymes was measured in normal cells (Figure 5, Panel A). An intricate network of proteins 
orchestrates the autophagic pathway. Beclin-1 is involved in the enrolment of membranes to 
form the autophagosome whereas p62 binds to LC3II (the membrane-associated form of the 
LC3 protein) and is finally degraded in autophagolysosomes, thus its levels inversely 
correlate with the autophagic activity. Figure 5, panel C, shows a decrease in p62 levels in 
cancer cells, whereas a significant, cell-type dependent increase in beclin-1 levels was 
observed: in MCF10A cells, this increase was induced by the mix, but in cancer cells it was 
due to both formulations, mainly the one consisting of 100% EAAs. As for LC3, no changes 
were detected in normal cells and cancer cells showed a higher sensitivity to the 100% EAAs 
solution. Staining with MDC was used to additionally monitor the autophagic cascade [28]. 
These analyses revealed an increased uptake of MDC into vacuoles in cancer cells with the 
classical punctate pattern of MDC-labeled fluorescence, further corroborating the hypothesis 
that the AAs supplementation selectively induce autophagy (Figure 5, Panel B). In fact, by 
contrast, treated MCF10A cells exhibited a diffused distribution of MDC-labeled 
fluorescence. Interestingly, blocking autophagy using 3-MA magnified the cytotoxic effects 
of the AAs formulations in tumor cells (figure 1). This is likely due to the strict 
interdependence between UPS and autophagy, with autophagy activation occurring in 
response to proteasome inhibition (in cancer cells upon amino acids supplementation). The 
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3. DISCUSSION 
The relation between nutrition and cancer is an unresolved question with many possible 
answers since even its peculiar energy production from glucose is still debated [29]. Nutrients 
in the diet may influence cancer development [3, 6, 16, 18, 28]. Supplementation with 
balanced formulations of EAAs exerted positive effects in the prevention of several human 
pathologies, in the improvement of the quality of life, in reducing oxidative damage and in 
increasing average life span in mice [3, 6, 13, 14, 16, 17]. While AAs are indispensable for 
cells life, AAs-induced cytotoxicity is documented in cancer cells, but few data are available 
on the molecular mechanisms involved [6, 19, 30]. Here, we explored the effects of two AAs 
formulations, one composed of EAAs in ratios proved to be safe and efficient in mammals 
[4], and the other consisting of 85% EAAs and 15% NEAAs, on human HeLa and HCT116 
cancer cells and elucidated the mechanisms responsible for their ability to trigger apoptosis. 
Results on cell viability showed a cell-type dependent action of both formulations, 
particularly evident in HCT116 cells. Additionally, the reduction of PCNA together with 
caspase-3 activation, decreased levels of Mcl-1 and full-length PARP, and DNA 
fragmentation confirm that supplementation inhibits proliferation and suggest the 
involvement in inducing apoptosis in cancer cells. In particular, as revealed by the MTT 
assay in the presence of the inhibitor zVAD-fmk, the two mixtures induced a caspases-
mediated apoptosis. The anti-proliferative effects induced by some AAs mixtures on cancer 
cells were described in previous studies. Hagiwara et al. observed that essential branched 
chain amino acids (Leu/Ile/Val) prevented insulin-induced hepatic tumor cells proliferation 
by inducing apoptosis through suppression of the insulin/PI3K/Akt pathway and involving 
mTORC1 and mTORC2 [31]. mTORC1 drives cellular growth controlling numerous 
processes that regulate protein synthesis and degradation whereas mTORC2 functions 
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authors demonstrated that BCAAs suppress the PI3K/Akt pathway by inducing a negative 
feedback loop through mTORC1/S6K1 activation and suppressing mTORC2 kinase activity 
toward the kinase Akt [31]. Akt inhibition leads to the activation of FOXO3a pro-apoptotic 
transcription factor and, consequently, the expression of genes necessary for cell death [33, 
34]. On the other hand, mTORC2 activation due to the lack of some AAs necessary for 
completing protein synthesis induces and controls autophagic machinery switching on [35]. 
Considering the close relationship between the mechanisms controlling cell cycle progression 
and cell death programs and the role of the proteasome as a switchboard to proceed with 
proliferation or to undergo apoptosis [36], we hypothesized that proteolysis modulation could 
be one of the pathway through which AAs exert their pro-apoptotic effect. Data here reported 
show that 20S and 26S proteasomes were inhibited in cancer cells and that no variations in 
the activities were detectable in MCF10A cells, further evidencing the selective action of the 
two formulations. Proteasome inhibition induces in HCT116 and HeLa cells accumulation of 
p27 and p53, two proteins widely associated with apoptosis [36-38]. For example, treatment 
with antisense p27 oligonucleotide inhibited apoptosis induced by proteasome inhibitors in 
cancer cells suggesting that p27 accumulation is critical in triggering apoptosis [39]. 
Proteasome and autophagy, another intracellular pathway for protein degradation, intensively 
cooperate and regulate each other's activities [40-42]. Upon treatment with both AAs 
formulations, cancer cells show activation of cathepsin B and L, decreased levels of p62 and 
Beclin-1 accumulation as well as the increase of the membrane-associated LC3-II 
component. Our results therefore strengthen the concept of the strict interdependence 
between UPS and autophagy, with autophagy activation occurring in response to proteasome 
inhibition in HCT116 and HeLa cells upon AAs supplementation. Interestingly, autophagy 
inhibition using 3-MA, compromising the compensatory activation of this pathway, 
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involved in driving cancer cells to apoptosis representing a pro-survival as well as a pro-
apoptotic mechanism, depending on the cancer type, stage and microenvironment. It exerts 
cytoprotective effects during nutrient and growth factors deprivation due to its ability to 
recycle nutrients, to maintain cellular energy homeostasis degrading toxic aggregated 
proteins or damaged organelles. However, in other cellular settings, a continuous or 
excessively induced autophagy may ultimately favor cell death [43, 44]. Autophagy and 
apoptosis share some common pathways and sensing components, including Beclin-1 and 
caspases, and their activities are mutually controlled [45]. Additionally, as previously 
reported, autophagy activation may associate with an increased tendency of cancer cells to 
undergo apoptosis [46-48]. Thus, we observed that feeding with essential AAs rich mixtures 
selectively elicits proteasome inhibition and autophagy activation in cancer cells. Modulation 
of cellular autophagy inhibits cell proliferation and activates apoptotic pathway. Both 
formulations similarly affected the intracellular pathways investigated, with HCT116 cells 
more vulnerable than HeLa cells, without interfering with the same processes in normal cells. 
It is reasonable to think that the difference in the content of EAAs between the two mixtures 
(85% versus 100%) is insufficient to modify EAA effects on cell viability by autophagy 
activation. Indeed, serine, as main NEAA to reach a 15% ratio with 85% of EAA, was chosen 
with three main purposes: it is the most metabolically AA rapidly available both for energy 
production and transamination generating one pyruvate molecule, it has a role in maintaining 
folates charged of methyl groups [49], and, combined to EAA on the bases of our data, serine 
may have an anti-cancer effect as an allosteric activator of pyruvate kinase by tetramer 
formation (isoform PKM2) [50]. This may improve the drive of glucose to full oxidation into 
mitochondria allowing metabolic production of sufficient ROS necessary to activate the 
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Collectively, our data show that supplementation with mixtures rich in EAAs triggers the 
activation of death mechanisms in cancer cells. In particular, as suggested by Corsetti G. et 
al., being cancer cells mostly dependent on the environmental prevalent availability of NEAA 
for metabolic processes and cell proliferation, enriching their environment with EAAs may 
trigger specific pathways that are ultimately incompatible with proliferation and survival 
[19]. These data therefore represent an important pillar supporting the interest of studying 
physiological effects of nutrition in cancers cells thus characterizing peculiar fragilities of 
cancer. A promising source of new options for alternative treatments of this complex disease. 
 
4. MATERIALS AND METHODS 
4.1 Cell lines 
MCF10A (not transformed cells) and HeLa, HCT116, MCF7, HepG2, CaCo2 (cancer cells) 
were grown in D-MEM supplemented with 10% FBS, antibiotic and antimycotic. To avoid 
results misinterpretation, no other nutrients (EAAs or NEAAs) were added to media. 
MCF10A cells (an in vitro model for studying normal epithelial cell function) were cultured 
in a DMEM/F12 Ham’s mixture supplemented with 5% equine serum, 20 ng/mL EGF, 10 
μg/mL insulin, 0.5 mg/mL hydrocortisone, antibiotics and antimycotics. Cells were incubated 
with growth media at 37°C equilibrated with 95% air and 5% CO2 in flasks, 96- or 6-well 
plates depending on the assay. 
 
4.2 Amino acids treatment  
Cells were independently treated with a solution containing 100% EAAs or a mixture of 85% 
EAAs and 15% NEAAs (herein named as mix). Compositions are reported in tab 1. Suitable 
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followed by vortexing and sonication at 50°C for 30 minutes. Each cell line was treated with 
1% (w/v) of the 100% EAAs solution and of the mixture. Control cells were treated with the 
growth medium. Treatments ranged from 48 to 96 h.  
 
4.3 MTT Assay 
Cell viability was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay, an index of mitochondrial activity and cell viability. It is based on viable cell 
ability to convert a soluble yellow tetrazolium salt to a purple-blue formazan crystal by 
mitochondrial succinate dehydrogenase. After incubation with the AAs supplementations, 
media were replaced with serum-free media containing 0.5 mg/mL MTT. Plates were 
incubated at 37°C for 2h. After supernatant discard, the formazan product was solubilized in 
100µL of DMSO and absorbance was measured at 550 nm [52]. MTT was also carried out in 
the presence and in the absence of the caspase inhibitor zVAD-fmk (carbobenzoxy-valyl-
alanyl-aspartyl-[O-methyl]- fluoromethylketone, 10µM concentration in the assay, Sigma 
Aldrich) and of the autophagy inhibitor 3-methyladenine (5mM concentration in the assay, 3-
MA, Sigma Aldrich).  
 
4.4 Hoechst nuclear staining 
Once treated, cells (1x106 cells/mL) were fixed in methanol/acetic acid (3:1), incubated with 
0.05 mg/mL Hoechst 33258 nuclear stain for 15 min and observed using an inverted 
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4.5 DNA fragmentation  
Cell lines were seeded in six-well plates and treated with the 100% EAAs solution, the amino 
acid mixture and the medium as control for 72 h. The Buonanno et al. procedure was 
followed [53]. Pellets were suspended in lysis buffer (50 mM Tris-HCl pH 8, 10 mM EDTA, 
0.5% SDS, and 0.5 mg/mL proteinase K) and incubated at 50°C for 1 h. Once added 10 
mg/ml of RNase, lysates were incubated for 10 min at 70°C. DNA was precipitated with 
NaOAc pH 5.2 and ice-cold 100% EtOH, followed by incubation on ice for 10 min, and 
centrifugation at 10.000×g for 10 min. Pellets were collected and dissolved in sterile water. 
Finally, samples were resolved on a 1.8% agarose gel stained with ethidium bromide. 
 
4.6 Cell lysis 
Upon treatment, cells were harvested in PBS, centrifuged and the pellet was re-suspended in 
lysis buffer (20 mM Tris, pH 7.4, 250 mM sucrose, 1 mM EDTA and 5 mM 
β‐mercaptoethanol). Lysates were centrifuged at 12000×g for 15 min and the supernatants 
stocked at ‐80°C. Protein concentration was estimated following the Bradford method using 
bovine serum albumin as standard [54].   
 
4.7 Enzymatic activities  
The effects on the 20S proteasome were evaluated through fluorimetric assays using the 
following synthetic substrates: Leu-Leu-Al-Tyr-AMC for ChT-L, Leu-Ser-Thr-Arg-AMC for 
T-L, Leu-Leu-Glu-AMC for PGPH and Gly-Pro-Ala-Phe-Gly-pAB for BrAAP, whose test is 
performed with the addition of the aminopeptidase-N (APN) (EC 3.4.11.2) [55]. The 
incubation mixture contained 4 μg of cell lysates, the appropriate substrate and 50 mM Tris–
HCl pH 8.0, up to a final volume of 100 μL. Incubation was performed at 37°C, and after 60 
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aminobenzoic acid (pAB) was detected (AMC, λexc=365 nm, λem=449 nm; pAB, λexc=304 
nm, λem=664 nm) on a SpectraMax Gemini XPS microplate reader. The 26S proteasome 
ChT-L activity was tested using Suc-Leu-Leu-Val-Tyr-AMC as substrate and 50 mM Tris–
HCl pH 8.0 buffer containing 10 mM MgCl2, 1 mM dithiothreitol, and 2 mM ATP. The 
effective 20S proteasome contribution to short peptide cleavage was evaluated performing 
control experiments using (5 μM in the reaction mixture) Z-Gly-Pro-Phe-Leu-CHO and 
lactacystin, specific proteasome inhibitors, and then subtracting the obtained fluorescence 
values from the values obtained in cell lysates. 
Caspase-3 activity was measured with the fluorogenic Ac-Asp-Glu-Val-Asp-AMC synthetic 
substrate in 50 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5 mM CaCl2, 1mM EDTA, 0.1% 
CHAPS, 5 mM β-mercaptoethanol, pH 7.5. Upon 60 min incubation at 37°C, the 
fluorescence of hydrolyzed AMC was measured on a SpectraMax Gemini XPS microplate 
reader (λexc = 365 nm, λem= 449 nm). 
Cathepsin B and L proteolytic activities were measured as described by Tchoupè et al. [56] 
using the fluorogenic peptides Z-Arg-Arg-AMC and Z-Phe-Arg-AFC, respectively, at a final 
concentration of 5 μM. The mixture for cathepsin B, containing 7 μg of protein lysate, was 
pre-incubated in 100 mM PBS pH 6.0, 1 mM EDTA and 2 mM dithiothreitol for 5 min at 
30°C. Upon the addition of the substrate, the mixture was incubated for 15 min at 30°C. The 
mixture for cathepsin L, containing 7 μg of protein lysate, was incubated in 100 mM 
CH3COONa buffer pH 5.5, 1 mM EDTA and 2 mM dithiothreitol for 5 min at 30°C and, 
upon the addition of the substrate, the mixture was incubated for 15 min at 30°C. The 
fluorescence of the hydrolyzed AMC (λexc=365 nm, λem=449 nm) and 7-amino-4-
trifluoromethylcoumarin (AFC, λexc=397 nm, λem=500 nm) was detected on a SpectraMax 
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evaluated through control experiments performed using the specific inhibitor CA074Me and 
subtracting these values from the fluorescence values obtained by analyzing cell lysates.  
 
4.8 Western blotting 
Cell lysates (20 µg of total proteins) were resolved by 10% or 12% SDS PAGE and 
electroblotted onto PVDF membranes. Membranes with transferred proteins were incubated 
with primary and secondary antibodies to detect p27, ubiquitin, proliferating cell nuclear 
antigen (PCNA), p53, Mcl-1 and poly (ADP-ribose) polymerase (PARP) (Santa Cruz 
Biotech, Heidelberg, Germany). The immunoblot detection was performed with an ECL 
western blotting analysis system. Each gel was loaded with prestained molecular mass 
markers in the range of 20–120 kDa (Euroclone, Milan, Italy). Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was utilized as control for equal protein loading: membranes were 
stripped and reprobed for GAPDH. Film were analyzed using ImageJ software. Data were 
analyzed with Matlab (The MathWorks Inc., MA, USA).  
 
4.9 Monodansylcadaverine (MDC)  
Cells were independently treated with both AAs formulation for 72 h. The media were 
replaced with 50 µM MDC (Sigma) in serum-free medium. After 10 min incubation at 37°C, 
cells were washed three times with PBS and analyzed under a fluorescence microscope 
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4.10 Statistical analysis 
Results are expressed as mean values and standard deviation of results obtained from five 
separate experiments. Statistical analysis was performed with one-way ANOVA, followed by 
the Bonferroni test using SigmaStat 3.1 software (SPSS, Chicago, IL, USA). p-Values <0.05 
and <0.01 were  considered significant. 
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N-Acetyl Cysteine 0.97 0
Ornithine-α Ketoglutarate 2.42 0
  
*Both formulations contain cystine and methionine to match sulfur AAs needs without toxicity.  
**Tyrosine is present in both formulations, since, when calculating phenylalanine needs, it was considered that 
tyrosine is a NAEE only for the liver and partially for kidneys, which can derive it by hydroxylating 
























Figure 1: Effect of the two AAs mixtures on normal and cancer cells viability. The MTT 
assay was carried out to measure cell viability in MCF10A cells (not transformed cells) and 
HeLa, HCT116, MCF7, HepG2, CaCo2 cells (tumoral cell lines). Cells were treated with the 
two AA mixtures and with the caspase inhibitor z-VAD and the autophagy inhibitor 3-MA. 
Asterisks (*) represent significant data points with respect to untreated control cells (100%), 
hashtags (#) represent significant data points with respect to treated cells in the absence of 
inhibitors. Results are expressed as mean values and standard deviation obtained from five 
separate experiments. Statistical analysis was performed with one-way ANOVA, followed by 
the Bonferroni test using SigmaStat 3.1 software (SPSS, Chicago, IL, USA). p-Values <0.05 
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Figure 2: Effect of the two AAs mixtures on normal and cancer cells proliferation and 
apoptosis. Panels A and B: representative autoradiographic films obtained from the Western 
blotting for PCNA, PARP and Mcl-1 detection and relative densitometry. GAPDH was used 
as control for equal protein loading. Data points marked with an asterisk are statistically 
significant compared to the respective untreated control cells (*p<0.05). Panel C: caspase-3 
activity measured using the fluorogenic substrate Ac-Asp-Glu-Val-Asp-AMC (see section 2 
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Panel D: gel electrophoresis of DNA samples isolated from normal and cancer cells. Each 
experiment was conducted in triplicate. DNA fragments were separated using 1.8% agarose 
gel electrophoresis and visualized under UV light following staining with ethidium bromide. 
Results are expressed as mean values and standard deviation of results obtained from five 
separate experiments. Statistical analysis was performed with one-way ANOVA, followed by 
the Bonferroni test using SigmaStat 3.1 software (SPSS, Chicago, IL, USA). *p<0.05 
indicates a statistically significant difference compared with the respective untreated control 
cells. Panel E: upon treatment, cells were stained with Hoechst 33342 to visualize nuclei 





















This article is protected by copyright. All rights reserved. 
 
 
Figure 3: Effect of the two AAs mixtures on 20S proteasome. 20S proteasome activities in 
normal and cancer cells following treatment with 100% EAAs and the mix (1% final 
concentration) for 72 h (see section 2 for details). Values are expressed as fluorescence units 
(F.U.) and the asterisk (*, p<0.05) indicates significantly different values compared to 
respective untreated control cells. Results are expressed as mean values and standard 
deviation of results obtained from five separate experiments. Statistical analysis was 
performed with one-way ANOVA, followed by the Bonferroni test using SigmaStat 3.1 























Figure 4: Effect of the two AAs mixtures on UPS. Panel A: 26S ChT-L activity measured 
in normal and cancer cells following treatment with 100% EAAs and the mix (1% final 
concentration) for 72 h (see section 2 for further details). Values are expressed as 
fluorescence units (F.U.) and the asterisk (*, p<0.05) indicates significantly different values 
compared to respective untreated control cells. Panel B: representative autoradiographic films 
obtained from Western blotting of ubiquitin, p27 and p53 and relative densitometry. GAPDH 
was used as equal loading control. Results are expressed as mean values and standard 
deviation of results obtained from five separate experiments. Statistical analysis was 
performed with one-way ANOVA, followed by the Bonferroni test using SigmaStat 3.1 
software (SPSS, Chicago, IL, USA). *p<0.05 indicates significantly different values 
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Figure 5: Effect of the two AAs mixtures on autophagy. Panel A: cathepsin L and B 
activity after AAs treatment were measured using fluorogenic substrates (see section 2 for 
details). Specific activity is expressed as the amount of released product per minute per μg of 
total protein in the sample. *p<0.05 indicates significantly different results compared to the 
non-treated group. Panel B: upon treatments, normal and cancer cells were incubated with 
MDC and analyzed by fluorescence microscopy to visualize autophagic vacuoles. Panel C: 
expression of autophagic markers in cell lysates. Representative autoradiographic films 
obtained from Western blotting for the detection of LC3-II, beclin-1, p62 and GAPDH 
(loading control) and densitometry.  Results are expressed as mean values and standard 
deviation of results obtained from five separate experiments. Statistical analysis was 
performed with one-way ANOVA, followed by the Bonferroni test using SigmaStat 3.1 
software (SPSS, Chicago, IL, USA). *p<0.05 indicates significantly different results 
compared to the non-treated group. 
